Cargando…
Immunological monitoring of anticancer vaccines in clinical trials
Therapeutic anticancer vaccines operate by eliciting or enhancing an immune response that specifically targets tumor-associated antigens. Although intense efforts have been made for developing clinically useful anticancer vaccines, only a few Phase III clinical trials testing this immunotherapeutic...
Autores principales: | Ogi, Chizuru, Aruga, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782518/ https://www.ncbi.nlm.nih.gov/pubmed/24083085 http://dx.doi.org/10.4161/onci.26012 |
Ejemplares similares
-
Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
por: Okuyama, Ryuji, et al.
Publicado: (2013) -
Immunological monitoring for prediction of clinical response to antitumor vaccine therapy
por: Mikhaylova, Irina N., et al.
Publicado: (2018) -
Trial Watch: Peptide-based anticancer vaccines
por: Pol, Jonathan, et al.
Publicado: (2015) -
Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens
por: Aruga, Atsushi
Publicado: (2013) -
Immunologic Monitoring of Cellular Responses by Dendritic/Tumor Cell Fusion Vaccines
por: Koido, Shigeo, et al.
Publicado: (2011)